Ewing's sarcoma and primitive neuroectodermal family of tumors

Hematology/Oncology Clinics of North America

Volumn 19, Issue 3, 2005, Pages 501-525

  Carvajal, Richard ^a   Meyers, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IFOSFAMIDE; IMATINIB; INTERLEUKIN 2; IRINOTECAN; MELPHALAN; RAPAMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; TOPOTECAN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; BLOOD TOXICITY; BONE MARROW METASTASIS; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EWING SARCOMA; GASTROINTESTINAL STROMAL TUMOR; GROWTH DISORDER; HUMAN; IATROGENIC DISEASE; LUNG METASTASIS; MAXIMUM TOLERATED DOSE; MYELODYSPLASTIC SYNDROME; NEUROECTODERM TUMOR; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SARCOMA; SOFT TISSUE SARCOMA; STEM CELL TRANSPLANTATION;

BONE NEOPLASMS; BRAIN NEOPLASMS; CLINICAL TRIALS; FORECASTING; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE; SARCOMA, EWING'S;

EID: 20444386594     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2005.03.004     Document Type: Review

References (175)

1. J. Ewing Diffuse endothelioma of bone Proc NY Pathol Soc 1921 17 24
2. O. Delattre, J. Zucman, and T. Melot The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts N Engl J Med 331 1994 294 299
3. D. Schmidt, C. Herrman, and J. Jurgens Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma Cancer 68 1991 2251 2259
4. D.M. Parham, Y. Hijazi, and S.M. Steinberg Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior Hum Pathol 30 8 1999 911 918
5. R. Luksch, G. Sampietro, and P. Collini Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in children Tumori 85 2 1999 101 107
6. G. Bacci, S. Ferrari, and F. Bertoni Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the Istituto Rizzoli J Clin Oncol 18 2000 885 892
7. L.H. Wexler, W.H. Meyer, and D.M. Parham Neural differentiation and prognosis in peripheral primitive neuroectodermal tumor J Clin Oncol 18 2000 2187 2188
8. L.A.G. Ries, M.P. Eisner, and C.L. Kosary SEER Cancer Statistics Review, 1975-2001 2004 National Cancer Institute Bethesda (MD)
9. J.D. Buckley, T.W. Pendergrass, and C.M. Buckley Epidemiology of osteosarcoma and Ewing's sarcoma in childhood: a study of 305 cases from the Children's Cancer Group Cancer 83 1998 1440 1448
10. J.G. Gurney, R.K. Severson, and S. Davis Incidence of cancer in children in the United States Cancer 75 1995 2186 2195
11. A.P. Polednak Primary bone cancer incidence in black and white residents of New York state Cancer 55 1985 2883 2888
12. A. Glass, and J. Fraumeni Epidemiology of bone cancer in children J Natl Cancer Inst 44 1970 187 199
13. F. Li, J. Tu, and F. Liu Rarity of Ewing's sarcoma in China Lancet 1 1980 1255
14. W. Gou, W. Xu, and A.G. Huvos Comparative frequency of bone sarcomas among different racial groups Chin Med J (Engl) 112 1999 1101 1104
15. J. Zucman-Rossi, M.A. Batzer, and M. Stoneking Interethnic polymorphism of EWS intron 6: genome plasticity mediated by Alu retroposition and recombination Hum Genet 99 1997 357 363
16. J. Fraumeni Stature and malignant tumors of bone in childhood and adolescence Cancer 20 1967 967 973
17. T.W. Pendergrass, M.A. Foulkes, and L.L. Robison Stature and Ewing's sarcoma in childhood Am J Pediatr Hematol Oncol 6 1984 33 39
18. D.M. Winn, F.P. Li, and L.L. Robison A case-control study of the etiology of Ewing's sarcoma Cancer Epidemiol Biomarkers Prev 1 1992 525 532
19. E.A. Holly, D.A. Aston, and D.K. Ahn Ewing's bone sarcoma, paternal occupational exposure, and other factors Am J Epidemiol 135 1992 135
20. A.L. Hartley, J.M. Birch, and C.V. Blair Cancer Incidence in the families of children with Ewing's sarcoma J Natl Cancer Inst 83 13 1991 955 956
21. B. Novakovic, M.A. Tucker, and L. Wexler Risk of cancer in families of patients with Ewing's sarcoma family of tumors Ann Meet Am Assoc Cancer Res 35 1994 A1729
22. F.P. Li, J.F. Fraumeni, and J.J. Mulvihill A cancer family syndrome in twenty-four kindreds Cancer Res 48 1988 5358 5362
23. A. Craft, S. Cotterill, and A. Malcolm Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and The Medical Research Council Ewing's Tumor Study J Clin Oncol 16 11 1998 3628 3633
24. S.S. Donaldson, M. Torrey, and M.P. Link A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346 Int J Radiat Oncol Biol Phys 42 1 1998 125 135
25. J.G. Kennedy, S. Eustace, and R. Caufield Extraskeletal Ewing's sarcoma: a case report and review of the literature Spine 25 2000 1996 1999
26. C.M. Coffin, and L.P. Dehner Neurogenic tumors of soft tissue C.M. Coffin L.P. Dehner P.A. O'Shea Pediatric soft tissue tumors: a clinical, pathological, and therapeutic approach 1997 Williams and Wilkins Baltimore (MD) 80 132
27. S.J. Cotterill, S. Ahrens, and M. Paulussen Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group J Clin Oncol 18 17 2000 3108 3114
28. G. Bacci, S. Ferrari, and A. Longhi Prognostic significance of serum LDH in Ewing's sarcoma of bone Oncol Rep 6 4 1999 807 811
29. G. Bacci, P. Picci, and M. Mercuri Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma Acta Oncol 37 7-8 1998 671 676
30. M. Paulussen, S. Ahrens, and J. Dunst Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86 J Clin Oncol 19 6 2001 1818 1829
31. P. Rosito, A.F. Mancini, and R. Rondelli Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience Cancer 86 3 1999 421 428
32. A.G. Shankar, C.R. Pinkerton, and A. Atra Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG) Eur J Cancer 35 12 1999 1698 1704
33. H.E. Grier, M.D. Krailo, and N.J. Tarbell Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone N Engl J Med 348 8 2003 694 701
34. A. Aurias, C. Rimbaud, and D. Buffe Chromosomal translocations in Ewing's sarcoma N Engl J Med 309 1983 496 497
35. C. Turc-Carel, I. Philip, and M.-P. Berger Chromosomal translocations in Ewing's sarcoma N Engl J Med 309 1983 497
36. C. Turc-Carel, A. Aurias, and F. Mugneret Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12) Cancer Genet Cytogenet 32 1988 229
37. C.T. Denny Gene rearrangements in Ewing's sarcoma Cancer Invest 14 1 1996 83 88
38. J. Bridge Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery J Bone Joint Surg Am 75 4 1993 606
39. J. Zucman, O. Delattre, and C. Desmaze Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoint Genes Chromosomes Cancer 5 1992 271
40. E. De Alava, A. Kawai, and J.H. Healey EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma J Clin Oncol 16 4 1998 1248 1255
41. E. De Avala, A. Panizo, and C.R. Antonescu Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma Am J Pathol 156 2000 849 855
42. M. Peter, J. Couturier, and H. Pacquement A new member of the ETS family fused to EWS in Ewing tumors Oncogene 14 1997 1159
43. F. Urano, A. Umezawa, and H. Yabe Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis Jpn J Cancer Res 89 7 1998 703 711
44. T. Ozaki, M. Paulussen, and C. Poremba Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors Genes Chromosomes Cancer 32 2 2001 164 171
45. H.Y. Huang, P.B. Illei, and Z. Zhao Ewing sarcomas with p53 mutation or p16/p14 ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse J Clin Oncol 23 3 2005 548 558
46. G. Amir, J. Issakov, and I. Meller Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome Hum Pathol 33 2002 170 174
47. G. Wei, C.R. Antonescu, and E. de Alava Prognostic impact on INK4 deletion in Ewing's sarcoma Cancer 89 2000 793 799
48. C.M. Hattinger, S. Rumpler, and S. Strehl Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors Genes Chromosomes Cancer 24 3 1999 243 254
49. D.C. Dahlin, M.B. Coventry, and P. Scanlon Ewing's sarcoma J Bone Joint Surg Am 43A 1961 185 192
50. S.K. Bhansali, and P.B. Desai Ewing's sarcoma: observation on 107 cases J Bone Joint Surg Am 45A 1963 541 553
51. J.T. Phelan, and A. Cabrera Ewing's sarcoma Surg Gynecol Obstet 118 1964 795 800
52. S. Falk, and M. Alpert Five-year survival of patients with Ewing's sarcoma Surg Gynecol Obstet 124 1967 319 324
53. A.I. Freeman, C. Sachatello, and J. Gaeta An analysis of Ewing's tumor in children at Roswell Park Memorial Institute Cancer 29 1972 1563 1569
54. M.E. Nesbit Ewing's sarcoma CA Cancer J Clin 26 1976 174 180
55. D.C. West, H.E. Grier, and M.M. Swallow Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor J Clin Oncol 15 1997 583 588
56. A. Zoubek, R. Ladenstein, and R. Windhager Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation Int J Cancer 79 1998 56 60
57. C. Fagnou, J. Michon, and M. Peter Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor J Clin Oncol 16 1998 1707 1711
58. G. Schleiermacher, M. Peter, and O. Oberlin Increased risk of systemic relapses associated with bone marrow micrometastases and circulating tumor cells in localized Ewing tumor J Clin Oncol 21 1 2003 85 91
59. M.E. Nesbit Jr, E.A. Gehan, and E.O. Burgert Jr Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the first intergroup study J Clin Oncol 8 10 1990 1664 1674
60. N. Jaffe, D. Paed, and D. Traggis Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy Cancer 38 1976 1925 1930
61. G. Rosen, B. Caparros, and C. Mosende Curability of Ewing's sarcoma and considerations for future therapeutic trials Cancer 41 1978 888 899
62. H. Jurgens, U. Exner, and H. Gadner Multidisciplinary treatment of primary Ewing's sarcoma of bone: a 6-year experience of a European cooperative trial Cancer 61 1988 23 32
63. G. Bacci, A. Toni, and M. Avella Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy Cancer 63 1989 1477 1486
64. E. Barbieri, E. Emiliani, and G. Zini Combined therapy of localized Ewing's sarcoma of bone: analysis of results in 100 patients Int J Radiat Oncol Biol Phys 19 1990 1165 1170
65. T.J. Kinsella, J.S. Miser, and B. Waller Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy Int J Radiat Biol Phys 20 1991 389 395
66. J.S. Wunder, G. Paulian, and A.G. Huvos The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma J Bone Joint Surg Am 80 7 1998 1020 1033
67. O. Oberlin, M.C. Deley, and B.N. Bui Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) Br J Cancer 85 11 2001 1646 1654
68. J.P. Dyke, D.M. Panicek, and J.H. Healey Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging Radiology 228 1 2003 271 278
69. A.W. Craft, S.J. Cotterill, and J.A. Bullimore Long-term results from the first UKCCSG Ewing's tumor study (ET-1) Eur J Cancer 33 1997 1061 1069
70. T. Ozaki, A. Hillman, and C. Hoffman Significance of surgical margin on the prognosis of patients with Ewing's sarcoma Cancer 78 1996 892 900
71. M. Sluga, R. Windhager, and S. Lang The role of surgery and resection margins in the treatment of Ewing sarcoma Clin Orthop 392 2001 394 399
72. R.M. Terek, E.W. Brien, and R.C. Marcove Treatment of femoral Ewing's sarcoma Cancer 78 1996 70 78
73. T. Ozaki, A. Hillmann, and C. Hoffmann Ewing's sarcoma of the femur Acta Orthop Scand 68 1997 20 24
74. G. Bacci, M. Mercuri, and A. Longhi Neoadjuvant chemotherapy for Ewing's tumor of bone: recent experience at the Rizzoli Orthopaedic Institute Eur J Cancer 38 2002 2243 2251
75. E.O. Burgert, M.E. Nesbit, and L.A. Garsney Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS-II J Clin Oncol 8 1990 1514 1524
76. J. Dunst, C. Hoffmann, and S. Ahrens Surgery versus radiotherapy in Ewing's sarcoma with good prognosis. Analysis of the CESS 86 data Strahlenther Onkol 172 1996 244 248
77. R.M. Wilkins, D.J. Pritchard, and E.O. Burgert Ewing's sarcoma of bone: Experience with 140 patients Cancer 58 1986 2551 2555
78. T.E. Merchant, B.H. Kushner, and J.M. Sheldon Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma Med Pediatr Oncol 33 1999 65 70
79. G. Bacci, S. Ferrari, and F. Bertoni Prognostic factors in non-metastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ostopedico Rizzoli J Clin Oncol 18 2000 4 11
80. A. Schuck, C. Rube, and S. Konemann Postoperative radiotherapy in the treatment of Ewing tumors: influence of the interval between surgery and radiotherapy Strahlenther Onkol 178 2002 25 31
81. J. Dunst, H. Jurgens, and R. Sauer Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial Int J Radiat Oncol Biol Phys 32 1995 919 930
82. G. Bacci, P. Picci, and S. Ferrari Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase - results of two sequential studies Cancer 82 1998 1174 1183
83. N.M. Marina, A.S. Pappo, and D.M. Parham Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round cell tumor: a feasibility study at St. Jude Children's Research Hospital J Clin Oncol 17 1999 180 190
84. M.E. Haggard Cyclophosphamide (NSC-26271) in the treatment of children with malignant neoplasms Cancer Chemother Rep 51 1967 403 405
85. M.L. Samuels, and C.D. Howe Cyclophosphamide in the management of Ewing's sarcoma Cancer 20 1967 961 966
86. R. Johnson, and D.R. Humphreys Past failures and future possibilities in Ewing's sarcoma: experimental and preliminary clinical results Cancer 23 1969 161 166
87. R.K. Oldham, and T.C. Pomeroy Treatment of Ewing's sarcoma with Adriamycin (NSC 123127) Cancer Chemother Rep 56 1972 635 639
88. F.A. Hayes, E.I. Thompson, and W.H. Meyer Therapy for localized Ewing's sarcoma of bone J Clin Oncol 7 1989 208 213
89. M. Salzer-Kuntschik, G. Delling, and G. Beron Morphological grades of regression in osteosarcoma after polychemotherapy-study COSS 80 J Cancer Res Clin Oncol 106 Suppl 1983 21 24
90. I. Magrath, J. Sandlund, and A. Raynor A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people Cancer Chemother Pharmacol 18 S2 1986 S25 S28
91. J.S. Miser, T.J. Kinsella, and T.J. Triche Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults J Clin Oncol 5 1987 1191 1198
92. K. Antman, L. Ryan, and A. Elias Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol 7 1989 126 131
93. H. Jurgens, U. Exner, and J. Kuhl High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma Cancer Chemother Pharmacol 24 S1 1989 S40 S44
94. F.H. Kung, C.B. Pratt, and R.A. Vega Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase II study Cancer 71 1993 1898 1903
95. A.C.S. Craft, and A. Malcolm Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and The Medical Research Council Ewing's Tumor Study J Clin Oncol 16 1998 3628 3633
96. O. Oberlin, J.L. Habrand, and J.M. Zucker No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology J Clin Oncol 10 1992 1737 1742
97. E.R. Lilly, M.C. Rosenberg, and G.B. Elion Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft Cancer Res 50 1990 284 287
98. F.H. Kung, C.B. Pratt, and R.A. Vega Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood Cancer 71 1993 1898 1903
99. Y. Yazawa, T. Takagi, and S. Asakura Effects of 4-hydroperoxyifosfamide in combination with other anticancer agents on human cancer cell lines J Orthop Sci 4 1999 231 237
100. V. Kurowski, and T. Wagner Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetylaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy Cancer Chemother Pharmacol 33 1993 36 42
101. P.I. Clark, M.L. Slevin, and S.P. Joel A randomized trial of two etoposide schedules in small-cell lung cancer: The influence of pharmacokinetics on efficacy and toxicity J Clin Oncol 12 1994 1427 1435
102. W.H. Meyer, L. Kun, and N. Marina Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone J Clin Oncol 10 1992 385 393
103. M. Paulussen, S. Ahrens, and G. Braun-Munzinger [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-preliminary results] Klin Padiatr 211 4 1999 276 283 [in German]
104. B. Kushner, P. Meyers, and W. Gerald Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults J Clin Oncol 13 1995 2796 2804
105. B.H. Kushner, M.P. LaQuaglia, and N. Wollner Desmoplastic small-round cell tumor: Prolonged progression free survival with aggressive multi-modality therapy J Clin Oncol 14 1996 1526 1531
106. R.B. Womer, R.T. Daller, and J.G. Fenton Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children Eur J Cancer 36 1 2000 87 94
107. F.B. Ruymann, T. Vietti, and E. Gehan Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma: a pilot study without hematopoietic growth factor support evaluating toxicity and response J Pediatr Hematol Oncol 17 1995 331 337
108. J.F. Kuttesch, L.H. Wexler, and R.B. Marcus Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas J Clin Oncol 14 1996 2818 2825
109. J. Miser, M. Krailo, and M. Smith Secondary leukemia (SL) or myelodysplastic syndrome (MDS) following therapy for Ewing's sarcoma (ES) [abstract] Proc Am Soc Clin Oncol 16 1997 518
110. E.A. Kolb, B.H. Kushner, and R. Gorlick Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults J Clin Oncol 21 18 2003 3423 3430
111. L. Granowetter, R. Womer, and M. Devidas Comparison of dose intensified and standard dose chemotherapy for the treatment of non-metastatic Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bone and soft tissue: a Pediatric Oncology Group-Children's Cancer Group phase III trial [abstract] Med Pedriatr Oncol 37 2001 172
112. R.B. Raney, L. Asmar, and W.A. Newton Jr Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991 J Clin Oncol 15 2 1997 574 582
113. M. Paulussen, S. Ahrens, and S. Burdach Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies Ann Oncol 9 3 1998 275 281
114. J.S. Miser, M.D. Krailo, and N.J. Tarbell Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide-a Children's Cancer Group and Pediatric Oncology Group study J Clin Oncol 22 14 2004 2873 2876
115. A. Cangir, T.J. Vietti, and E.A. Gehan Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two Intergroup Ewing's Sarcoma Studies Cancer 66 5 1990 887 893
116. C.R. Pinkerton, A. Bataillard, and S. Guillo Treatment strategies for metastatic Ewing's sarcoma Eur J Cancer 37 11 2001 1338 1344
117. L. Madero, A. Muñoz, and J. Sánchez de Toledo Megatherapy in children with high-risk Ewing's sarcoma in first complete remission Bone Marrow Transplant 21 8 1998 795 799
118. S.L. Spunt, M.B. McCarville, and L.E. Kun Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis J Pediatr Hematol Oncol 23 2 2001 93 98
119. C. Rodriguez-Galindo, C.A. Billups, and L.E. Kun Survival after recurrence of Ewing tumors: the St. Jude Children's Research Hospital Experience, 1979-1999 Cancer 94 2002 561 569
120. C.B. Pratt, C.F. Stewart, and V.M. Santana Phase I study of topotecan for pediatric patients with malignant solid tumors J Clin Oncol 12 1994 539 543
121. D.G. Tubergen, C.F. Stewart, and C.B. Pratt Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study J Pediatr Hematol Oncol 18 1996 352 361
122. R. Nitschke, J. Parkhurst, and J. Sullivan Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study J Pediatr Hematol Oncol 20 1998 315 318
123. H. Frangoul, M.M. Ames, and R.B. Mosher Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group Clin Cancer Res 5 1999 3956 3962
124. W.L. Furman, C.F. Stewart, and C.A. Poquette Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children J Clin Oncol 17 1999 1815 1824
125. S. Blaney, S.L. Berg, and C. Pratt A phase I study of irinotecan in pediatric patients: a pediatric oncology group study Clin Cancer Res 7 2001 32 37
126. R.L. Saylors III, K.C. Stine, and J. Sullivan Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study J Clin Oncol 19 15 2001 3463 3469
127. M.A. Cornbleet, R.E. Corringham, and H.G. Prentice Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation Cancer Treat Rep 65 1981 241 244
128. A.B. Jacobsen, E.A. Wist, and O.P. Solheim Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow rescue Monogr Ser Eur Organ Res Treat Cancer 14 1984 157 160
129. R.H. Herzig, G.L. Phillips, and H.M. Lazarus Intensive chemotherapy and autologous bone marrow transplantation for the treatment of refractory malignancies Proc First Int Symp Autologous Bone Marrow Transplantation 1 1985 197 202
130. G. Dini, O. Hartmann, and R. Pinkerton Autologous bone marrow transplantation in Ewing's sarcoma: an analysis of phase II studies from the European Bone Marrow Transplantation Group Proc Fourth Int Symp Autologous Bone Marrow Transplantation 39 1988 593 599
131. S. Burdach, H. Jurgens, and C. Peters Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma J Clin Oncol 11 1993 1482 1488
132. D.A. Stewart, E. Gyonyor, and A.H. Paterson High-dose melphalan +/- total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor Bone Marrow Transplant 18 1996 315 318
133. K.W. Chan, D. Petropoulos, and M. Choroszy High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors Bone Marrow Transplant 20 1997 1039 1043
134. A. Atra, J. Whelan, and V. Calvagna High-dose busulfan/melphalan with autologous stem cell rescue in Ewing's sarcoma Bone Marrow Transplant 20 1997 843 846
135. N. Lucidarme, D. Valteau-Couanet, and O. Oberlin Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors Bone Marrow Transplant 22 1998 535 540
136. M.F. Ozkaynak, K. Matthay, and M. Cairo Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors J Clin Oncol 16 1998 937 944
137. A. Prete, P. Rosito, and P. Alvisi G-CSF-primed peripheral blood progenitor cells (PBPC) support in high-risk Ewing sarcoma of childhood Bone Marrow Transplant 22 1998 S21 S23
138. E.A.D. Czyzewski, S. Goldman, and A.J. Mundt Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue: a feasibility study Int J Radiat Oncol Biol Phys 44 1999 569 577
139. J. Perentesis, E. Katsanis, and T. DeFor Autologous stem cell transplantation for high-risk pediatric solid tumors Bone Marrow Transplant 24 1999 609 615
140. S. Burdach, B. van Kaick, and H.J. Laws Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup Study EICESS Ann Oncol 11 2000 1451 1462
141. M.E. Horowitz, T.J. Kinsella, and L.H. Wexler Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma J Clin Oncol 11 1993 1911 1918
142. P.A. Meyers, M.D. Krailo, and M. Ladanyi High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis J Clin Oncol 19 2001 2812 2820
143. J.S. Miser, M. Krailo, and P. Meyers Metastatic Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bone: failure of new regimens to improve outcome [abstract] Proc Am Soc Clin Oncol 15 1996 467
144. B.H. Kushner, and P.A. Meyers How effective is dose-intensive/ myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering Experience and a literature review J Clin Oncol 19 2001 870 880
145. Barker L.M., Pendergrass T.W., Sanders J.E., et al. Survival after recurrence of Ewing's sarcoma family of tumors. J Clin Oncol, in press
146. R. Ladenstein, C. Lasset, and R. Pinkerton Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT solid tumor registry Bone Marrow Transplant 15 1995 697 705
147. R. Ladenstein, O. Hartmann, and R. Pinkerton A multivariate and matched pair analysis on high-risk Ewing tumor (ET) patients treated by megatherapy (MGT) and stem cell reinfusion (SCR) in Europe [abstract] Proc Am Soc Clin Oncol 18 1999 555
148. W. Leung, A.R. Chen, and R.C. Klann Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma Bone Marrow Transplant 22 1998 971 979
149. R. Bergan, F. Hakim, and G.N. Schwartz Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex-vivo bone marrow purging Blood 88 1996 731 741
150. M. Merino, F. Navid, and B. Christensen Immunomagnetic purging of Ewing's sarcoma from blood: quantitation by real-time PCR [abstract] Proc Am Soc Clin Oncol 19 2000 593
151. M.L. Disis, and M.A. Cheever Oncogenic proteins as tumor antigens Curr Opin Immunol 8 1996 634 642
152. R. Champlin, I. Khouri, and S. Komblau Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect Oncology 13 1999 621 628
153. R.W. Childs, E. Clave, and J. Tisdale Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect J Clin Oncol 17 1999 2044 2050
154. M.S. Staege, G. Hansen, and G. Baersch Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy Pediatr Blood Cancer 43 1 2004 23 34
155. S. Burdach, W. Nurnberger, and H.J. Laws Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors Bone Marrow Transplant 18 1996 S67 S68
156. R. Ladenstein, C. Peters, and A. Zoubek The role of megatherapy (MGT) followed by stem cell rescue (SCR) in high risk Ewing tumors (ET). 11 years single center experience [abstract] Med Pediatr Oncol 27 1996 237
157. W. Emminger, W. Emminger-Schmidmeier, and C. Peters Is treatment intensification by adding etoposide and carboplatin to fractionated total body irradiation and melphalan acceptable in children with solid tumors with respect to toxicity? Bone Marrow Transplant 8 1991 119 123
158. J. Dunst, S. Ahrens, and M. Paulussen Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies Int J Radiat Oncol Biol Phys 42 2 1998 379 384
159. M. Paulussen, S. Ahrens, and M. Lehnert Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study Ann Oncol 12 11 2001 1619 1630
160. B. Fuchs, R.G. Valenzuela, and I.A. Petersen Ewing's sarcoma and the development of secondary malignancies Clin Orthop 415 2003 82 89
161. B.H. Kushner, G. Heller, and N.K. Cheung High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors J Clin Oncol 16 9 1998 3016 3020
162. C. Rodriguez-Galindo, C.A. Poquette, and N.M. Marina Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors J Pediatr Hematol Oncol 22 2000 321 329
163. J.P. Neglia, D.L. Friedman, and Y. Yasui Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study J Natl Cancer Inst 93 8 2001 618 629
164. M.M. Hawkins, L.M. Wilson, and H.S. Burton Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer J Natl Cancer Inst 88 5 1996 270 278
165. B.E. Smithey, A.S. Pappo, and D.A. Hill C-kit expression in pediatric solid tumors: a comparative immunohistochemical study Am J Surg Pathol 26 4 2002 486 492
166. E. Ricotti, F. Fagioli, and E. Garelli c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells Blood 91 7 1998 2397 2405
167. B.J. Druker, M. Talpaz, and D.J. Resta Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 344 14 2001 1031 1037
168. B.J. Druker, C.L. Sawyers, and H. Kantarjian Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 344 14 2001 1038 1042
169. G.D. Demetri, M. von Mehren, and C.D. Blanke Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 7 2002 472 480
170. R. Chugh, D. Thomas, and P. Wathen Imatinib mesylate in soft tissue and bone sarcomas: interim results of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial J Clin Oncol 22 14S 2004 9001
171. J.A. Toretsky, T. Kalebic, and V. Blakesley The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts J Biol Chem 272 49 1997 30822 30827
172. S. Benini, M.C. Manara, and N. Baldini Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells Clin Cancer Res 7 6 2001 1790 1797
173. J.A. Toretsky, M. Thakar, and A.E. Eskenazi Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors Cancer Res 59 22 1999 5745 5750
174. J.A. Toretsky, S.M. Steinberg, and M. Thakar Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors Cancer 92 11 2001 2941 2947
175. M. Hidalgo, and E.K. Rowinsky The rapamycin-sensitive signal transduction pathway as a target for cancer therapy Oncogene 19 56 2000 6680 6686